148 related articles for article (PubMed ID: 29750782)
1. Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth.
Ménard M; Costechareyre C; Ichim G; Blachier J; Neves D; Jarrosson-Wuilleme L; Depping R; Koster J; Saintigny P; Mehlen P; Tauszig-Delamasure S
PLoS Biol; 2018 May; 16(5):e2002912. PubMed ID: 29750782
[TBL] [Abstract][Full Text] [Related]
2. The dependence receptor TrkC triggers mitochondria-dependent apoptosis upon Cobra-1 recruitment.
Ichim G; Genevois AL; Ménard M; Yu LY; Coelho-Aguiar JM; Llambi F; Jarrosson-Wuilleme L; Lefebvre J; Tulasne D; Dupin E; Le Douarin N; Arumäe U; Tauszig-Delamasure S; Mehlen P
Mol Cell; 2013 Sep; 51(5):632-46. PubMed ID: 24034695
[TBL] [Abstract][Full Text] [Related]
3. HEY1 functions are regulated by its phosphorylation at Ser-68.
López-Mateo I; Arruabarrena-Aristorena A; Artaza-Irigaray C; López JA; Calvo E; Belandia B
Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27129302
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis.
Bouzas-Rodriguez J; Cabrera JR; Delloye-Bourgeois C; Ichim G; Delcros JG; Raquin MA; Rousseau R; Combaret V; Bénard J; Tauszig-Delamasure S; Mehlen P
J Clin Invest; 2010 Mar; 120(3):850-8. PubMed ID: 20160348
[TBL] [Abstract][Full Text] [Related]
5. Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: a new antitumoral strategy.
Tauszig-Delamasure S; Bouzas-Rodriguez J
Expert Opin Ther Targets; 2011 Jul; 15(7):847-58. PubMed ID: 21473736
[TBL] [Abstract][Full Text] [Related]
6. The dependence receptor TrkC regulates the number of sensory neurons during DRG development.
Ménard M; Costechareyre C; Coelho-Aguiar JM; Jarrosson-Wuilleme L; Rama N; Blachier J; Kindbeiter K; Bozon M; Cabrera JR; Dupin E; Le Douarin N; Mehlen P; Tauszig-Delamasure S
Dev Biol; 2018 Oct; 442(2):249-261. PubMed ID: 30071216
[TBL] [Abstract][Full Text] [Related]
7. HeyL regulates the number of TrkC neurons in dorsal root ganglia.
Mukhopadhyay A; Jarrett J; Chlon T; Kessler JA
Dev Biol; 2009 Oct; 334(1):142-51. PubMed ID: 19631204
[TBL] [Abstract][Full Text] [Related]
8. The Neurotrophin Receptor TrkC as a Novel Molecular Target of the Antineuroblastoma Action of Valproic Acid.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360553
[TBL] [Abstract][Full Text] [Related]
9. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
[TBL] [Abstract][Full Text] [Related]
10. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm.
Tauszig-Delamasure S; Yu LY; Cabrera JR; Bouzas-Rodriguez J; Mermet-Bouvier C; Guix C; Bordeaux MC; Arumäe U; Mehlen P
Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13361-6. PubMed ID: 17686986
[TBL] [Abstract][Full Text] [Related]
11. Identification of p53 regulators by genome-wide functional analysis.
Huang Q; Raya A; DeJesus P; Chao SH; Quon KC; Caldwell JS; Chanda SK; Izpisua-Belmonte JC; Schultz PG
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3456-61. PubMed ID: 14990790
[TBL] [Abstract][Full Text] [Related]
12. HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions.
Villaronga MA; Lavery DN; Bevan CL; Llanos S; Belandia B
Oncogene; 2010 Jan; 29(3):411-20. PubMed ID: 19802006
[TBL] [Abstract][Full Text] [Related]
13. Dok5 is involved in the signaling pathway of neurotrophin-3 against TrkC-induced apoptosis.
Pan Y; Zhang J; Liu W; Shu P; Yin B; Yuan J; Qiang B; Peng X
Neurosci Lett; 2013 Oct; 553():46-51. PubMed ID: 23954828
[TBL] [Abstract][Full Text] [Related]
14. Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.
Lu J; Guan S; Zhao Y; Yu Y; Wang Y; Shi Y; Mao X; Yang KL; Sun W; Xu X; Yi JS; Yang T; Yang J; Nuchtern JG
Oncotarget; 2016 Dec; 7(50):82757-82769. PubMed ID: 27764791
[TBL] [Abstract][Full Text] [Related]
15. TXNIP interacts with hEcd to increase p53 stability and activity.
Suh HW; Yun S; Song H; Jung H; Park YJ; Kim TD; Yoon SR; Choi I
Biochem Biophys Res Commun; 2013 Aug; 438(2):264-9. PubMed ID: 23880345
[TBL] [Abstract][Full Text] [Related]
16. A tryptophanol-derived oxazolopiperidone lactam is cytotoxic against tumors via inhibition of p53 interaction with murine double minute proteins.
Soares J; Raimundo L; Pereira NA; dos Santos DJ; Pérez M; Queiroz G; Leão M; Santos MM; Saraiva L
Pharmacol Res; 2015; 95-96():42-52. PubMed ID: 25814188
[TBL] [Abstract][Full Text] [Related]
17. Dependence receptor TrkC is a putative colon cancer tumor suppressor.
Genevois AL; Ichim G; Coissieux MM; Lambert MP; Lavial F; Goldschneider D; Jarrosson-Wuilleme L; Lepinasse F; Gouysse G; Herceg Z; Scoazec JY; Tauszig-Delamasure S; Mehlen P
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3017-22. PubMed ID: 23341610
[TBL] [Abstract][Full Text] [Related]
18. Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway.
Yamaguchi Y; Takenobu H; Ohira M; Nakazawa A; Yoshida S; Akita N; Shimozato O; Iwama A; Nakagawara A; Kamijo T
Eur J Cancer; 2014 May; 50(8):1555-65. PubMed ID: 24559687
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
[TBL] [Abstract][Full Text] [Related]
20. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
